FDA Pulls Heartburn Drug Zantac From Market
WEDNESDAY, April 1, 2020 -- All versions of the heartburn drug Zantac (ranitidine) have been pulled from the U.S. market due to possible contamination with a probable cancer-causing chemical, the U.S. Food and Drug Administration said...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Chemistry | Food and Drug Administration (FDA) | General Medicine | Heartburn | Ranitidine